BM
Bridger Management Portfolio holdings
AUM
$170M
This Quarter Return
+10.45%
1 Year Return
+22.51%
3 Year Return
+156.88%
5 Year Return
+225.78%
10 Year Return
+854.42%
AUM
$1.42B
AUM Growth
+$1.42B
(-5.1%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-12.27%
Top 10 Holdings %
Top 10 Hldgs %
45.84%
Holding
51
New
8
Increased
9
Reduced
10
Closed
13
Top Buys
| 1 |
MDCO
Medicines Co
MDCO
|
$54M |
| 2 |
TRLA
TRULIA INC (DEL)
TRLA
|
$42.6M |
| 3 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$37.8M |
| 4 |
ECOM
CHANNELADVISOR CORPORATION
ECOM
|
$31.6M |
| 5 |
Labcorp
LH
|
$31.5M |
Top Sells
| 1 |
SAVE
Spirit Airlines, Inc.
SAVE
|
$59.4M |
| 2 |
Merck
MRK
|
$55.4M |
| 3 |
Eli Lilly
LLY
|
$47.4M |
| 4 |
Vodafone
VOD
|
$41.9M |
| 5 |
UnitedHealth
UNH
|
$36.4M |
Sector Composition
| 1 | Healthcare | 34.99% |
| 2 | Consumer Discretionary | 25.84% |
| 3 | Financials | 10.66% |
| 4 | Communication Services | 8.04% |
| 5 | Technology | 7.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
PennyMac Financial
PFSI
$5.83B
| $29.2M | 2.06% |
1,925,000
| – | – |
|
27
Accuray
ARAY
$165M
| $26.4M | 1.86% |
3,000,000
| – | – |
|
28
TG Therapeutics
TGTX
$5.03B
| $23.9M | 1.68% |
2,547,000
| – | – |
|
29
Vipshop
VIPS
$8.36B
| $16.4M | 1.16% |
+87,500
| New | +$16.4M |
|
30
Zillow
ZG
$19.6B
| $12.1M | 0.85% |
+85,000
| New | +$12.1M |
|
|
IDIX
31
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
| $11.4M | 0.81% |
474,800
-1,025,200
| -68% | -$24.7M |
|
32
Churchill Downs
CHDN
$7.12B
| $9.01M | 0.63% |
100,000
| – | – |
|
33
Agios Pharmaceuticals
AGIO
$2.36B
| $8.42M | 0.59% |
+183,700
| New | +$8.42M |
|
34
Cardiff Oncology
CRDF
$130M
| $7.5M | 0.53% |
2,142,857
| – | – |
|
|
RGDX
35
DELISTED
RESPONSE GENETICS, INC COMMON SHS (DELAWARE)
RGDX
| $5.52M | 0.39% |
6,000,000
| – | – |
|
|
CSFL
36
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $4.89M | 0.34% |
+436,536
| New | +$4.89M |
|
|
SODA
37
DELISTED
SodaStream International Ltd
SODA
| $4.37M | 0.31% |
130,000
+15,000
| +13% | +$504K |
|
38
Casella Waste Systems
CWST
$6.07B
| $2.79M | 0.2% |
555,933
-640,217
| -54% | -$3.21M |
|
39
Bruker
BRKR
$4.45B
| – | – |
-815,000
| Closed | -$18.6M |
|
40
Liberty Global Class A
LBTYA
$4.03B
| – | – |
-210,000
| Closed | -$8.74M |
|
41
Liberty Global Class C
LBTYK
$4.1B
| – | – |
-210,000
| Closed | -$8.55M |
|
|
42
Eli Lilly
LLY
$661B
| – | – |
-805,000
| Closed | -$47.4M |
|
|
43
Merck
MRK
$210B
| – | – |
-975,000
| Closed | -$55.4M |
|
44
Polaris
PII
$3.22B
| – | – |
-190,000
| Closed | -$26.5M |
|
45
Regeneron Pharmaceuticals
REGN
$59.8B
| – | – |
-55,000
| Closed | -$16.5M |
|
|
46
UnitedHealth
UNH
$279B
| – | – |
-443,544
| Closed | -$36.4M |
|
|
47
Vodafone
VOD
$28.2B
| – | – |
-1,139,544
| Closed | -$41.9M |
|
48
Verastem
VSTM
$585M
| – | – |
-200,000
| Closed | -$2.16M |
|
49
Zoetis
ZTS
$67.6B
| – | – |
-1,134,538
| Closed | -$32.8M |
|
|
SAVE
50
DELISTED
Spirit Airlines, Inc.
SAVE
| – | – |
-1,000,000
| Closed | -$59.4M |
|